Low levels of ventricular CSF orexin/hypocretin in advanced PD
- 26 August 2003
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 61 (4) , 540-543
- https://doi.org/10.1212/01.wnl.0000078194.53210.48
Abstract
The origins of excessive daytime sleepiness in Parkinson disease (PD) are unclear. The authors hypothesize that orexin neurons, a recently identified wake promoting system, could contribute to its pathophysiology. They measured orexin-A/hypocretin-1 concentration in ventricular CSF in 19 parkinsonian patients and compared it with neurologic controls. Orexin levels were lower in patients and decreased with the severity of the disease. The authors suggest that orexin neurons contribute to daytime sleepiness in late stage PD.Keywords
This publication has 8 references indexed in Scilit:
- Contributions of Dopaminergic Drugs and Disease Severity to Daytime Sleepiness in Parkinson DiseaseArchives of Neurology, 2002
- Parkinson’s disease and sleepinessNeurology, 2002
- Normal hypocretin-1 levels in Parkinson’s disease patients with excessive daytime sleepinessNeurology, 2002
- CSF hypocretin/orexin levels in narcolepsy and other neurological conditionsNeurology, 2001
- The hypocretin/orexin ligand–receptor system: implications for sleep and sleep disordersTrends in Neurosciences, 2000
- Excessive daytime sleepiness and sleep benefit in Parkinson's disease: A community-based studyMovement Disorders, 1999
- Orexin A-like immunoreactivity in the rat brainNeuroscience Letters, 1999
- The hypothalamus in parkinson diseaseAnnals of Neurology, 1978